Logo image of CMPR

CIMPRESS PLC (CMPR) Stock Fundamental Analysis

NASDAQ:CMPR - Nasdaq - IE00BKYC3F77 - Common Stock - Currency: USD

53.19  -2.12 (-3.83%)

After market: 53.19 0 (0%)

Fundamental Rating

4

Taking everything into account, CMPR scores 4 out of 10 in our fundamental rating. CMPR was compared to 84 industry peers in the Commercial Services & Supplies industry. There are concerns on the financial health of CMPR while its profitability can be described as average. CMPR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CMPR was profitable.
In the past year CMPR had a positive cash flow from operations.
CMPR had negative earnings in 4 of the past 5 years.
Of the past 5 years CMPR 4 years had a positive operating cash flow.
CMPR Yearly Net Income VS EBIT VS OCF VS FCFCMPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

CMPR's Return On Assets of 8.27% is fine compared to the rest of the industry. CMPR outperforms 78.57% of its industry peers.
CMPR has a better Return On Invested Capital (15.20%) than 88.10% of its industry peers.
CMPR had an Average Return On Invested Capital over the past 3 years of 8.68%. This is below the industry average of 11.60%.
The 3 year average ROIC (8.68%) for CMPR is below the current ROIC(15.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.27%
ROE N/A
ROIC 15.2%
ROA(3y)-1.12%
ROA(5y)-0.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.68%
ROIC(5y)8.7%
CMPR Yearly ROA, ROE, ROICCMPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

CMPR's Profit Margin of 4.61% is fine compared to the rest of the industry. CMPR outperforms 64.29% of its industry peers.
CMPR's Profit Margin has improved in the last couple of years.
CMPR has a Operating Margin of 6.85%. This is comparable to the rest of the industry: CMPR outperforms 54.76% of its industry peers.
CMPR's Operating Margin has improved in the last couple of years.
The Gross Margin of CMPR (47.91%) is better than 86.90% of its industry peers.
In the last couple of years the Gross Margin of CMPR has remained more or less at the same level.
Industry RankSector Rank
OM 6.85%
PM (TTM) 4.61%
GM 47.91%
OM growth 3Y10.14%
OM growth 5Y2.48%
PM growth 3YN/A
PM growth 5Y8.82%
GM growth 3Y-0.7%
GM growth 5Y-0.23%
CMPR Yearly Profit, Operating, Gross MarginsCMPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CMPR is creating value.
There is no outstanding debt for CMPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CMPR Yearly Shares OutstandingCMPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CMPR Yearly Total Debt VS Total AssetsCMPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.57 indicates that CMPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
CMPR has a Altman-Z score (2.57) which is comparable to the rest of the industry.
The Debt to FCF ratio of CMPR is 9.29, which is on the high side as it means it would take CMPR, 9.29 years of fcf income to pay off all of its debts.
CMPR has a Debt to FCF ratio (9.29) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.29
Altman-Z 2.57
ROIC/WACC2.15
WACC7.08%
CMPR Yearly LT Debt VS Equity VS FCFCMPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CMPR has a Current Ratio of 0.65. This is a bad value and indicates that CMPR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CMPR (0.65) is worse than 88.10% of its industry peers.
A Quick Ratio of 0.50 indicates that CMPR may have some problems paying its short term obligations.
CMPR has a Quick ratio of 0.50. This is amonst the worse of the industry: CMPR underperforms 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.5
CMPR Yearly Current Assets VS Current LiabilitesCMPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

CMPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.14%.
Measured over the past years, CMPR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -39.82% on average per year.
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5Y-39.82%
EPS Q2Q%-123.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.43%

3.2 Future

Based on estimates for the next years, CMPR will show a very strong growth in Earnings Per Share. The EPS will grow by 137.07% on average per year.
CMPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.23% yearly.
EPS Next Y463%
EPS Next 2Y137.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.16%
Revenue Next 2Y3.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMPR Yearly Revenue VS EstimatesCMPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CMPR Yearly EPS VS EstimatesCMPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 104.29, CMPR can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CMPR is valued a bit more expensive than 60.71% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.82, CMPR is valued quite expensively.
CMPR is valuated rather expensively with a Price/Forward Earnings ratio of 18.52.
Based on the Price/Forward Earnings ratio, CMPR is valued a bit cheaper than 67.86% of the companies in the same industry.
CMPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 104.29
Fwd PE 18.52
CMPR Price Earnings VS Forward Price EarningsCMPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CMPR is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CMPR indicates a rather cheap valuation: CMPR is cheaper than 90.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.59
EV/EBITDA 7.43
CMPR Per share dataCMPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

CMPR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CMPR has a very decent profitability rating, which may justify a higher PE ratio.
CMPR's earnings are expected to grow with 137.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y137.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CMPR!.
Industry RankSector Rank
Dividend Yield N/A

CIMPRESS PLC

NASDAQ:CMPR (8/1/2025, 8:00:00 PM)

After market: 53.19 0 (0%)

53.19

-2.12 (-3.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-28 2025-10-28
Inst Owners83.74%
Inst Owner Change-0.47%
Ins Owners9.8%
Ins Owner Change10.34%
Market Cap1.32B
Analysts85
Price Target63.75 (19.85%)
Short Float %9.47%
Short Ratio7.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-81.8%
Min EPS beat(2)-158.82%
Max EPS beat(2)-4.78%
EPS beat(4)1
Avg EPS beat(4)-0.5%
Min EPS beat(4)-269.03%
Max EPS beat(4)430.64%
EPS beat(8)4
Avg EPS beat(8)42.6%
EPS beat(12)5
Avg EPS beat(12)-17.51%
EPS beat(16)7
Avg EPS beat(16)-24.77%
Revenue beat(2)0
Avg Revenue beat(2)-3.72%
Min Revenue beat(2)-4.43%
Max Revenue beat(2)-3.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.65%
Min Revenue beat(4)-4.43%
Max Revenue beat(4)-1.22%
Revenue beat(8)1
Avg Revenue beat(8)-2.22%
Revenue beat(12)3
Avg Revenue beat(12)-1.96%
Revenue beat(16)5
Avg Revenue beat(16)-1.41%
PT rev (1m)0%
PT rev (3m)-31.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.97%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 104.29
Fwd PE 18.52
P/S 0.39
P/FCF 7.59
P/OCF 4.19
P/B N/A
P/tB N/A
EV/EBITDA 7.43
EPS(TTM)0.51
EY0.96%
EPS(NY)2.87
Fwd EY5.4%
FCF(TTM)7.01
FCFY13.18%
OCF(TTM)12.69
OCFY23.86%
SpS135.3
BVpS-22.41
TBVpS-60.63
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.27%
ROE N/A
ROCE 19.24%
ROIC 15.2%
ROICexc 17.94%
ROICexgc 281.28%
OM 6.85%
PM (TTM) 4.61%
GM 47.91%
FCFM 5.18%
ROA(3y)-1.12%
ROA(5y)-0.53%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.68%
ROIC(5y)8.7%
ROICexc(3y)10.44%
ROICexc(5y)10.24%
ROICexgc(3y)164.51%
ROICexgc(5y)116.75%
ROCE(3y)10.99%
ROCE(5y)11.01%
ROICexcg growth 3Y76.95%
ROICexcg growth 5Y40.7%
ROICexc growth 3Y26.5%
ROICexc growth 5Y11.72%
OM growth 3Y10.14%
OM growth 5Y2.48%
PM growth 3YN/A
PM growth 5Y8.82%
GM growth 3Y-0.7%
GM growth 5Y-0.23%
F-Score6
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.29
Debt/EBITDA 4.32
Cap/Depr 100.37%
Cap/Sales 4.2%
Interest Coverage 1.74
Cash Conversion 85.01%
Profit Quality 112.36%
Current Ratio 0.65
Quick Ratio 0.5
Altman-Z 2.57
F-Score6
WACC7.08%
ROIC/WACC2.15
Cap/Depr(3y)70.41%
Cap/Depr(5y)64.99%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5Y-39.82%
EPS Q2Q%-123.56%
EPS Next Y463%
EPS Next 2Y137.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.43%
Revenue Next Year3.16%
Revenue Next 2Y3.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.5%
EBIT growth 3Y19.53%
EBIT growth 5Y6.22%
EBIT Next Year76.63%
EBIT Next 3Y21.6%
EBIT Next 5YN/A
FCF growth 1Y268.84%
FCF growth 3Y12.75%
FCF growth 5Y2.32%
OCF growth 1Y101.98%
OCF growth 3Y9.76%
OCF growth 5Y1.16%